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The intestinal mucosa harbors trillions of commensal bacteria that provide the host with nutrients
and contribute to resistance to infections but, in certain instances, also potentiate the generation of
proinflammatory cells. Recent studies unveil how this delicate balance is achieved and how it can
be manipulated for therapeutic purposes.Commensal-derived butyrate facilitates the differ-
entiation of regulatory T cells in the colonic
mucosa. Figure courtesy of H. Ohno.Butyrate Boosts Tregs
Different members of the intestinal microbiota contribute to anti-inflamma-
tory and proinflammatory responses, but the molecular signals driving
these two opposite outcomes are unclear. Germ-free mice lack the
intestinal microbiota and have been previously shown to have reduced
anti-inflammatory regulatory T cells (Tregs) in the colonic mucosa. Hiroshi
Ohno and colleagues (Furusawa et al., 2013) demonstrate that recolo-
nization of these mice with chloroform-resistant bacteria (CRB) restores
the population of colonic Tregs. This is potentiated by a high-fiber diet,
suggesting that microbial metabolites may affect the generation of
Tregs. Using a metabolomics approach, they find that short-chain fatty
acids, especially butyrate, were enriched in the caecal content and
colonic tissue of mice fed a high-fiber diet. Importantly, butyrate poten-
tiates the generation of colonic Tregs in vivo, and treatment with buty-
rate reduces the severity of inflammation in a mouse model of colitis.
These results are corroborated by the accompanying report by Sasha
Rudensky and colleagues (Arpaia et al., 2013), showing that butyrateproduced by commensal microbes stimulates the differentiation of Tregs in vitro. Further, the authors track the effect
of commensal-derived butyrate and find that it acts by facilitating the generation of extrathymic Tregs. The precise
mechanisms underlying this effect are complex and involve multiple direct and indirect effects of butyrate in T cells.
Indeed, butyrate not only increases the stability of Foxp3 protein through histone acetylation and induction of
epigenetic changes in the Foxp3 gene regulatory sequences in T cells, but also endows dendritic cells with the ability
to facilitate the differentiation of Tregs. These two studies provide valuable evidence that the immune system can sense
commensal microbe byproducts and use that information to tune pro- and anti-inflammatory activity in the intestinal
mucosa.
Furusawa, Y., et al. (2013). Nature 504, 446–450.
Arpaia, N., et al. (2013). Nature 504, 451–455.Epigenetic Barrier in the Mucosa
Histone deacetylases modify the epigenome, affect gene expression, and are regulated both by endogenous factors
and environmental signals. Artis and colleagues (Alenghat et al., 2013) now show that conditional deletion of his-
tone deacetylase 3 (HDAC3) in intestinal epithelial cells results in extensive alterations in gene expression and
disorganization of the mucosal barrier, with loss of Paneth cells, impaired function of intestinal epithelial cells,
and alterations in the composition of the gut microbiota, ultimately leading to increased susceptibility to intestinal
damage and inflammation. Unexpectedly, elimination of the commensal flora by rederivation of HDAC3-deficient
mouse into germ-free condition restores the functionality of the mucosal barrier. Although the new data strongly
suggest that HDAC3 mediates the crosstalk between commensals and intestinal epithelial cells, future studies
will be required to define the diversity of molecular mechanisms underlying the control of HDAC3 activity in epithe-
lial cells.
Alenghat, T., et al. (2013). Nature 504, 153–157.Cell 156, January 16, 2014 ª2014 Elsevier Inc. 7
Model of RegIIIa pore complex con-
structed by docking the RegIIIa crystal
structure into a cryo-EM density map.
Figure courtesy of L. Hooper and
S. Mukherjee.Planning a Selective Attack
Discriminating between invasive dangerous microbes and mutualistic commensal
bacteria at the mucosal barriers is a challenging task. Lora Hooper and colleagues
(Mukherjee et al., 2013) show that C-type lectins of the RegIII family are well suited
for this complex task. They report that RegIIIa mediates bacterial killing by binding
to phospholipids in the bacterial membrane, forming a hexameric oligomeric pore
that renders the membrane permeable. Importantly, lipopolysaccharide, a compo-
nent of the outer layer of the Gram-negative bacterial cell wall, inhibits the activity
of RegIIIa, thus explaining how RegIIIa specifically kills Gram-positive bacteria. This
mechanism may allow efficient protection of the intestinal barrier against invasive
bacteria while simultaneously tolerating the existence of abundant commensal
Gram-negative species.
Mukherjee, S., et al. (2014). Nature 505, 103–107.Mouse gut bacteria phylogenetic tree superim-
posedoveramicrophotographof small intestine tis-
sue. Figure courtesy of G. Trinchieri and A. Dzutsev.Microbiota against the Cancer
Beyond their local effect in the mucosa, intestinal commensal microbes can
affect inflammation and immunity systemically. Trinchieri, Goldszmid, and
colleagues (Iida et al., 2013) report that disruption of the microbiota by anti-
biotic treatment impairs tumor response to immunotherapy and platinum
chemotherapy in a mouse model of subcutaneous tumor. In the absence
of an intactmicrobiota, myeloid cells infiltrating the tumormicroenvironment,
which are important mediators of the effects of immunotherapy and
contribute to the cytotoxic effect of anticancer drugs, produce less inflam-
matory cytokines and are deficient in the production of reactive species of
oxygen. These results highlight the importance of the microbiota in deter-
mining the outcome of the response to cancer therapy. Indeed, in a related
report, Zitvogel and colleagues (Viaud et al., 2013) observe that cyclophos-
phamide, an important drug for cancer treatment, alters the composition of
the intestinal microbiota and promotes translocation of selected Gram-
positive bacteria species to the secondary lymphoid organs. In that location,
these bacteria stimulate the differentiation of effector Th17 cells that, in turn,
are required to mediate the cytotoxic antitumor effect of the drug. The
molecular mechanism behind the induction of Th17 cells by these members
of the microbiota is still unclear. Therefore, these two studies show that manipulation of the intestinal microbiota may poten-
tially be useful to boost chemotherapy and immunotherapy for cancer in humans.
Iida, N., et al. (2013). Science 342, 967–970.
Viaud, S., et al. (2013). Science 342, 971–976.
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